1-48759164-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001302082.2(BEND5):c.-27G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000241 in 1,614,078 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001302082.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BEND5 | NM_024603.4 | c.481G>T | p.Val161Leu | missense_variant | Exon 3 of 6 | ENST00000371833.4 | NP_078879.2 | |
AGBL4 | NM_032785.4 | c.635-95923G>T | intron_variant | Intron 6 of 13 | ENST00000371839.6 | NP_116174.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BEND5 | ENST00000371833.4 | c.481G>T | p.Val161Leu | missense_variant | Exon 3 of 6 | 1 | NM_024603.4 | ENSP00000360899.3 | ||
AGBL4 | ENST00000371839.6 | c.635-95923G>T | intron_variant | Intron 6 of 13 | 2 | NM_032785.4 | ENSP00000360905.1 |
Frequencies
GnomAD3 genomes AF: 0.000282 AC: 43AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000227 AC: 57AN: 250676Hom.: 0 AF XY: 0.000214 AC XY: 29AN XY: 135530
GnomAD4 exome AF: 0.000237 AC: 346AN: 1461836Hom.: 3 Cov.: 33 AF XY: 0.000246 AC XY: 179AN XY: 727226
GnomAD4 genome AF: 0.000282 AC: 43AN: 152242Hom.: 0 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.481G>T (p.V161L) alteration is located in exon 3 (coding exon 3) of the BEND5 gene. This alteration results from a G to T substitution at nucleotide position 481, causing the valine (V) at amino acid position 161 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at